Mutated p53 in tumors, mutant p53 and p53-specific antibodies in the circulation in patients with gastric cancer

Journal of Experimental and Clinical Cancer Research

Volumn 19, Issue 4, 2000, Pages 489-495

  Maeta, M ^a   Saito, H ^a   Oka, S ^a   Tsujitani, S ^a   Ikeguchi, M ^a   Kaibara, N ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Circulating mutant p53; Circulating p53 specific antibodies; Gastric cancer; Mutant p53; Prognostic factor

Indexed keywords

ANTIBODY; PROTEIN P53;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034465481     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. The p53 proto-oncogene can act as a suppressor of transformation
2. Genetic mechanisms of tumor suppression by the human p53 gene
3. Suppression of human colorectal carcinoma cell growth by wild-type p53
4. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
5. p53-dependent apoptosis suppresses tumor growth and progression in vivo
6. p53: At the crossroad of molecular carcinogenesis and risk assessment
7. The p53 tumor suppressor gene
8. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: Comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings
9. p53 in colorectal cancer: Clinicopathological correlation and prognostic significance
10. p53 mutations, another breast cancer prognostic factor
11. Levels of p53 antigen in the plasma of patients with adenomas and carcinomas of the colon
12. Mutant plasma p53 protein levels: Prognostication in colorectal carcinoma
13. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot
14. Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer
15. Serum p53 antibodies as early markers of lung cancer
16. Clinicopathological significance of the expression of mutated p 53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma
17. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
18. The prognostic significance of the accumulation of p53 tumor-suppressor gene protein in gastric adenocarcinoma
19. Expression of p53 protein in gastric carcinomas
20. The clinical significance of p53 accumulation in gastric carcinoma
21. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer
22. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis
23. Expression of p21 (waf1/cip 1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric cancer
24. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus
25. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations
26. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines
27. Increased expression of mutant forms of p53 oncogene in primary lung cancer
28. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis
29. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
30. Cytoplasmic accumulation of p53 protein: An independent prognostic indicator in colorectal adenocarcinomas
31. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation
32. Antibodies to the p53 tumor suppressor gene product quantified in cancer patients serum with a time-resolved immunofluorometry technique
33. Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers
34. p53 antibodies in patients with various types of cancer: Assay, identification and characterization
35. Monitoring of p53 autoantibodies in lung cancer during therapy: Relationship to response to treatment
36. Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer
37. Clinical significance of serum p53 antibody in patients with gastric cancer